← Back to Search

Behavioural Intervention

NeuroMetrix for Peripheral Neuropathy

N/A
Waitlist Available
Led By Hye Sook Chon, MD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 30 days after 3 week treatment sessions
Awards & highlights

Study Summary

This trial will test the validity of a new, point-of-care nerve conduction device and a common tuning fork in assessing the level of chemotherapy-induced peripheral neuropathy in patients.

Eligible Conditions
  • Peripheral Neuropathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 30 days after 3 week treatment sessions
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 30 days after 3 week treatment sessions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accessing Level of Peripheral Neuropathy
Secondary outcome measures
Nail-Patella Syndrome
Quality of life Improvement measured with FACT/GOG-NTX Questionnaire

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants Receiving ElectroacupunctureExperimental Treatment3 Interventions
Participants will receive electroacupuncture for 30 minutes once per week for a total of 3 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NeuroMetrix
2020
N/A
~30
Electroacupuncture
2012
Completed Phase 3
~1800
Rydel-Seiffer tuning fork
2020
N/A
~30

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
542 Previous Clinical Trials
135,469 Total Patients Enrolled
Hye Sook Chon, MDPrincipal InvestigatorMoffitt Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)
2020. "Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04092764.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top